Mycophenolate mofetil hydrochloride is the generic ingredient in one branded drug marketed by Roche Palo and is included in one NDA. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.
There are thirty-three drug master file entries for mycophenolate mofetil hydrochloride. One supplier is listed for this compound. There is one tentative approval for this compound.
|Drug Class||Antimetabolite Immunosuppressant |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
mycophenolate mofetil hydrochloride
|INJECTABLE;INJECTION||050758||Aug 12, 1998||RX||Yes||5,543,408||<disabled>||Y||<disabled>|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.